About this trial
Wedge-Shaped Clusterded Randomizad Trial to Evaluate Two Tools to identify People at Risk or already Infected with HIV and HCV
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Having already been included in the study, not signing the consent.
Trial design
Sequential
Treatments tested in this trial
rapid HIV and HCV serological tests
Diagnostic testIn the standard of care branch (SOC), the health personnel will ask people a series of questions to identify the HIV risk exposition, and also they will be provided pop-up computer alerts of HIV indicator conditions in the electronic medical record, moreover HIV and HCV serological tests will be carried out in the reference laboratory, while in the intervention branch in addition to the SOC, a SQ-R\&IC of HIV and HCV will be made available to the HC population, through a quick response (QR) code, as well as HIV and HCV RT.
Treatment groups
Trial outcomes
Primary outcomes
Implementation of a risk and indicator conditions self-questionnaire SQ-R&IC for HIV and HCV infection, in addition to rapid HIV and HCV serological tests
Number of Participants With the implementation of a risk and indicator conditions self-questionnaire SQ-R\&IC for HIV and HCV infection, in addition to rapid HIV and HCV serological tests, Change From Baseline in hidden and incident HIV and HCV infection at 3 Years
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Collaborator
European Union
Collaborator